These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8444668)
21. Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci. Hirano L; Bayer AS Antimicrob Agents Chemother; 1991 Apr; 35(4):685-90. PubMed ID: 2069374 [TBL] [Abstract][Full Text] [Related]
22. Endocarditis due to high-level gentamicin-resistant Enterococcus faecalis. Lee PY; Das SS Postgrad Med J; 1995 Feb; 71(832):117-9. PubMed ID: 7724425 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251 [TBL] [Abstract][Full Text] [Related]
24. Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin. Hindes RG; Willey SH; Eliopoulos GM; Rice LB; Eliopoulos CT; Murray BE; Moellering RC Antimicrob Agents Chemother; 1989 Jul; 33(7):1019-22. PubMed ID: 2506803 [TBL] [Abstract][Full Text] [Related]
25. [Current role of penicillin antibiotics: focused on sulbactam sodium/ampicillin sodium. Discussion]. Jpn J Antibiot; 1994 Nov; 47(11):1421-32. PubMed ID: 7853672 [No Abstract] [Full Text] [Related]
26. High-level aminoglycoside-resistant enterococcus causing endocarditis successfully treated with a combination of ampicillin, imipenem and vancomycin. Antony SJ; Ladner J; Stratton CW; Raudales F; Dummer SJ Scand J Infect Dis; 1997; 29(6):628-30. PubMed ID: 9571747 [TBL] [Abstract][Full Text] [Related]
27. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations]. Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus. Thauvin-Eliopoulos C; Rice LB; Eliopoulos GM; Moellering RC Antimicrob Agents Chemother; 1990 May; 34(5):728-32. PubMed ID: 2360813 [TBL] [Abstract][Full Text] [Related]
30. Infective endocarditis caused by Enterococcus faecalis treated with continuous infusion of ampicillin without adjunctive aminoglycosides. Ogawa T; Sato M; Yonekawa S; Nakagawa C; Uno K; Kasahara K; Maeda K; Konishi M; Mikasa K Intern Med; 2013; 52(10):1131-5. PubMed ID: 23676604 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method. Tascini C; Doria R; Leonildi A; Martinelli C; Menichetti F J Chemother; 2004 Aug; 16(4):400-3. PubMed ID: 15332717 [TBL] [Abstract][Full Text] [Related]
32. Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis. Luque-Paz D; Cuervo G; Miró JM; Tattevin P Clin Microbiol Infect; 2023 Jun; 29(6):676-678. PubMed ID: 36889644 [No Abstract] [Full Text] [Related]
33. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model. Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900 [TBL] [Abstract][Full Text] [Related]
34. Successful treatment with ampicillin and fluoroquinolones of human endocarditis due to high-level gentamicin-resistant enterococci. Tripodi MF; Locatelli A; Adinolfi LE; Andreana A; Utili R Eur J Clin Microbiol Infect Dis; 1998 Oct; 17(10):734-6. PubMed ID: 9865990 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Gavaldà J; Torres C; Tenorio C; López P; Zaragoza M; Capdevila JA; Almirante B; Ruiz F; Borrell N; Gomis X; Pigrau C; Baquero F; Pahissa A Antimicrob Agents Chemother; 1999 Mar; 43(3):639-46. PubMed ID: 10049280 [TBL] [Abstract][Full Text] [Related]
36. Endocarditis after ciprofloxacin therapy for enterococcal pyelonephritis with bacteremia. McDonald GR J Tenn Med Assoc; 1993 Dec; 86(12):527-8. PubMed ID: 8295423 [No Abstract] [Full Text] [Related]
37. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase]. Moittie D; Simonet M; Veron M Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362 [TBL] [Abstract][Full Text] [Related]
38. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Friedel HA; Campoli-Richards DM; Goa KL Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196 [TBL] [Abstract][Full Text] [Related]
39. Antibiotic resistance among enterococci causing endocarditis in the UK: analysis of isolates referred to a reference laboratory. Johnson AP; Warner M; Woodford N; Speller DC; Livermore DM BMJ; 1998 Sep; 317(7159):629-30. PubMed ID: 9727989 [No Abstract] [Full Text] [Related]